Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893837 · ClinicalTrials.gov registry record
Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)
A clinical trial of Brain Injuries, Traumatic, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 399
- Enrollment target
- 2
- Study locations
NCT04893837: Completed study of Brain Injuries, Traumatic, sponsored by University of Alabama at Birmingham.
NCT04893837 is a study of Brain Injuries, Traumatic that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 399 participants, above the 237-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (68% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04893837, a study of Brain Injuries, Traumatic, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
- 2
- Study locations
Study Summary
MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.
Primary Outcome
Number of participants whose Infrascan results were accurate
Conditions Studied
Interventions
- DEVICE Standard care plus infrascans
Study Locations (2)
Alabama
- UAB Hospital - Birmingham
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2025-08-25 |
What the finished NCT04893837 record still lists
NCT04893837 is an observational study that tracks outcomes without assigning an intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap, above the 237-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (68% higher).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Standard care plus infrascans is the first listed.
NCT04893837 reports a single indexed study location in Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT04893837 about?
NCT04893837 is a clinical study titled "Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)". MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.
What is the current status of trial NCT04893837?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2022-04-18. Estimated completion is 2025-08-25.
What conditions does trial NCT04893837 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT04893837?
The interventions under investigation include: Standard care plus infrascans (DEVICE).
Who is sponsoring clinical trial NCT04893837?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04893837 being conducted?
This trial has 2 study locations across Alabama, Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04893837's enrollment target sits among peer trials
399 5th of 21 higher than 17 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
mTBI Identification and Monitoring Through Retinal Scanning
RECRUITING
-
Automated Robotic TCD in Traumatic Brain Injury
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI